OA05.03 Safety and Clinical Activity of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes (TIL) Combined With Nivolumab in NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.259

Related search